NEWS
Free Institutional Consultancy Services
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Xu Chuanhui
Tan Tock Seng Hospital - Singapur / Singapore
Medical and Health Sciences / Rheumatology
AD Scientific Index ID: 4965325
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Xu Chuanhui's MOST POPULAR ARTICLES
1-)
Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosusJ He, X Zhang, Y Wei, X Sun, Y Chen, J Deng, Y Jin, Y Gan, X Hu, R Jia, ...Nature medicine 22 (9), 991-993, 20165202016
2-)
Implantable and degradable antioxidant poly (ε-caprolactone)-lignin nanofiber membrane for effective osteoarthritis treatmentR Liang, J Zhao, B Li, P Cai, XJ Loh, C Xu, P Chen, D Kai, L ZhengBiomaterials 230, 119601, 20201112020
3-)
HLA dependent immune escape mechanisms in B-cell lymphomas: Implications for immune checkpoint inhibitor therapy?M Nijland, RN Veenstra, L Visser, C Xu, K Kushekhar, GW van Imhoff, ...Oncoimmunology 6 (4), e1295202, 20171022017
4-)
Clinical outcomes of COVID-19 in patients with rheumatic diseases: a systematic review and meta-analysis of global dataC Xu, Z Yi, R Cai, R Chen, BYH Thong, R MuAutoimmunity reviews 20 (4), 102778, 2021772021
5-)
Societal costs of rheumatoid arthritis in China: a hospital‐based cross‐sectional studyC Xu, X Wang, R Mu, L Yang, Y Zhang, S Han, X Li, Y Wang, G Wang, ...Arthritis care & research 66 (4), 523-531, 2014592014
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept